Global Autoimmune Disease Diagnostics Market 2017-2021

Publisher Name :
Date: 30-Sep-2016
No. of pages: 134
Price : Single User: US $ 3500  US $ 2500 Corporate User: US $ 5000  US $ 4000
Inquire Before Buying
Avail $1000 Discount on this report till 31st December, 2017. To avail discount please contact at +1-888-391-5441 / sales@rnrmarketresearch.com.

Abnormal immune responses of the innate immune system can cause autoimmune diseases, which can damage body tissues and lead to abnormal organ functions. Immunological complications due to physiological processes within the human body lead to autoimmune diseases. These diseases are characterized by chronic inflammatory processes that activate the innate immune system and the production of antibodies that destroy host tissues. These inflammatory processes can be caused by genetic or environmental factors or infections.

This analyst forecast the global autoimmune disease diagnostics market to grow at a CAGR of 6.39% during the period 2017-2021.

Covered in this report

This report covers the present scenario and the growth prospects of the global autoimmune disease diagnostics market for 2017-2021. To calculate the market size, we use the revenue generated from the sales of various diagnostic tests for autoimmune diseases.

The market is divided into the following segments based on geography:


  • Americas

  • APAC

  • EMEA


The report, Global Autoimmune Disease Diagnostics Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. This report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors


  • Abbott Laboratories

  • Beckman Coulter

  • Bio-Rad Laboratories

  • Inova Diagnostics

  • Siemens Healthcare

  • Thermo Fisher Scientific


Other prominent vendors


  • AESKU Diagnostics

  • Alere

  • Autoimmune Technologies

  • Bio-Diagnostics

  • bioMérieux

  • Diarect

  • DiaSorin

  • Erba Diagnostics

  • Euro Diagnostica

  • EUROIMMUN

  • Exagen Diagnostics

  • Gold Standard Diagnostics

  • HUMAN Diagnostics

  • ImmunArray

  • KRONUS

  • Menarini

  • Myriad Genetics

  • Omega Diagnostics

  • ORGENTEC Diagnostika

  • Protagen

  • Qiagen

  • Quest Diagnostics

  • Roche Diagnostics

  • Seramun Diagnostica

  • SQI Diagnostics

  • Tecan


Market driver


  • Discovery of novel biomarkers

  • For a full, detailed list, view our report


Market challenge


  • Lack of skilled laboratory technicians

  • For a full, detailed list, view our report


Market trend


  • Shift from monoplex to multiplex testing

  • For a full, detailed list, view our report


Key questions answered in this report


  • What will the market size be in 2020 and what will the growth rate be?

  • What are the key market trends?

  • What is driving this market?

  • What are the challenges to market growth?

  • Who are the key vendors in this market space?

  • What are the market opportunities and threats faced by the key vendors?

  • What are the strengths and weaknesses of the key vendors?

Avail $1000 Discount on this report till 31st December, 2017. To avail discount please contact at +1-888-391-5441 / sales@rnrmarketresearch.com.

Global Autoimmune Disease Diagnostics Market 2017-2021

Table of Contents

PART 01: Executive summary
Highlights

PART 02: Scope of the report
Market overview
Top-vendor offerings

PART 03: Market research methodology
Research methodology
Economic indicators

PART 04: Introduction
Key market highlights
Autoimmune diseases

PART 05: Market landscape
Market overview
Five forces analysis

PART 06: Market segmentation by disease type
Systemic autoimmune disease diagnostics
Global systemic autoimmune disease market overview
Localized autoimmune disease diagnostics
Global localized autoimmune disease diagnostics market overview

PART 07: Market segmentation by product type
Analyzers
Global autoimmune diseases analyzers market overview
Assay kits
Global autoimmune disease assay kits market overview

PART 08: Market segmentation by test type
ANA tests
CRP
Urinalysis test
ESR
CMP test
Other

PART 09: Market segmentation by end-user
Hospitals
Diagnostic and research laboratories

PART 10: Geographical segmentation
Autoimmune disease diagnostics market in Americas
Autoimmune disease diagnostics market in EMEA
Autoimmune disease diagnostics market in APAC

PART 11: Market drivers
Discovery of novel biomarkers leading to improved autoimmune diagnosis
Advancements in laboratory automation platforms
Increasing M&A
Product approvals and launches

PART 12: Impact of drivers

PART 13: Market challenges
Limitation of autoimmune disease diagnostics
Significant concerns over standardization and quality of immunoassay kits
Lack of understanding on the basic etiology of several autoimmune diseases
Shortage of skilled technicians for performing diagnostic assays

PART 14: Impact of drivers and challenges

PART 15: Market trends
Focus on companion diagnostic tests
Shift from monoplex to multiplex testing
Collaboration between pharma and diagnostic companies
Growing consumer shift toward direct-to-consumer testing

PART 16: Vendor landscape
Competitive scenario
Key news
Vendors market share 2015

PART 17: Key vendor analysis
Abbott Laboratories
Beckman Coulter
Bio-Rad Laboratories
EUROIMMUN
Inova Diagnostics
Roche Diagnostics
Siemens Healthcare
Other prominent vendors

PART 18: Appendix
List of abbreviations

List of Exhibits

Exhibit 01: Product offerings
Exhibit 02: Etiology of autoimmune diseases
Exhibit 03: Signs and symptoms of autoimmune diseases
Exhibit 04: Average annual treatment cost of RA in US and Europe 2014 ($ billions)
Exhibit 05: Average annual treatment costs of multiple sclerosis across countries 2014 ($ billions)
Exhibit 06: Snapshot of global autoimmune disease diagnostics market 2016-2021
Exhibit 07: Global autoimmune disease diagnostics market snapshot
Exhibit 08: Key trends in global autoimmune disease diagnostics market
Exhibit 09: Global autoimmune disease diagnostics market 2016-2021 ($ millions)
Exhibit 10: Opportunity analysis in developed and emerging markets
Exhibit 11: Opportunity analysis of global autoimmune diagnostics market
Exhibit 12: Five forces analysis
Exhibit 13: Global autoimmune disease diagnostics market segmentation by disease type
Exhibit 14: Global systemic autoimmune disease diagnostics market 2016
Exhibit 15: Global localized autoimmune disease diagnostics market 2016
Exhibit 16: Global autoimmune disease diagnostics market segmentation by disease type 2016
Exhibit 17: Global autoimmune disease diagnostics market segmentation by disease type 2016
Exhibit 18: Antibodies for diagnosis of different systemic autoimmune diseases
Exhibit 19: Global systemic autoimmune disease diagnostics market 2016-2021 ($ millions)
Exhibit 20: Global RA diagnostics market 2016-2021 ($ millions)
Exhibit 21: Prevalence and incidence of SLE
Exhibit 22: Global SLE diagnostics market overview 2016-2021 ($ millions)
Exhibit 23: Global systemic autoimmune disease diagnostics market measurement parameters
Exhibit 24: Opportunity analysis of systemic autoimmune disease market
Exhibit 25: Antibodies used for diagnosis of different localized autoimmune diseases
Exhibit 26: Global localized autoimmune disease diagnostics market 2016-2021 ($ millions)
Exhibit 27: Opportunity analysis of localized autoimmune disease diagnostics market
Exhibit 28: Global type 1 diabetes diagnostics market 2016-2021 ($ millions)
Exhibit 29: Global autoimmune thyroiditis diagnostics market 2016-2021 ($ millions)
Exhibit 30: Global localized autoimmune disease diagnostics market measurement parameters
Exhibit 31: Global autoimmune disease diagnostics market segmentation by disease type 2016-2021 ($ millions)
Exhibit 32: Global autoimmune disease diagnostics market segmentation by disease type 2016-2021
Exhibit 33: Analysis of autoimmune disease diagnostics market segmentation by disease type
Exhibit 34: Global autoimmune disease diagnostics market segmentation by product type
Exhibit 35: Global autoimmune disease diagnostics market segmentation by product type 2016-2021
Exhibit 36: Global autoimmune disease diagnostics market segmentation by product type 2016
Exhibit 37: Global autoimmune disease diagnostics market segmentation by product type 2016
Exhibit 38: Some of the analyzers developed by vendors
Exhibit 39: Global autoimmune diseases analyzers market 2016-2021 ($ millions)
Exhibit 40: Opportunity analysis of autoimmune disease analyzers market
Exhibit 41: Some of the assays kits available in the market
Exhibit 42: Some of the key news related to assay kits
Exhibit 43: Global autoimmune diseases assay kits market 2016-2021 ($ millions)
Exhibit 44: Opportunity analysis for autoimmune disease assay kits
Exhibit 45: Analysis of autoimmune disease diagnostics market by product type
Exhibit 46: Global autoimmune disease diagnostics market by product type 2016-2021 ($ millions)
Exhibit 47: Global autoimmune disease diagnostics market by product type 2016-2021
Exhibit 48: Global autoimmune disease diagnostics market segmentation by test type
Exhibit 49: Global autoimmune disease diagnostics market segmentation by test type
Exhibit 50: Some of the examples of ANA tests
Exhibit 51: Global autoimmune disease diagnostics market segmentation by geography 2016-2021
Exhibit 52: Global autoimmune disease diagnostics market segmentation by geography 2016
Exhibit 53: Global autoimmune disease diagnostics market segmentation by geography 2016
Exhibit 54: Global autoimmune disease diagnostics market segmentation by geography 2016-2021 ($ millions)
Exhibit 55: Global autoimmune disease diagnostics market segmentation by geography 2016-2021
Exhibit 56: Americas: Market overview of autoimmune disease diagnostics
Exhibit 57: Comparison of US healthcare system: Before and after reforms
Exhibit 58: Autoimmune disease diagnostics market in Americas 2016-2021 ($ millions)
Exhibit 59: Autoimmune disease diagnostics market in EMEA 2016-2021 ($ millions)
Exhibit 60: EMEA: Market overview of autoimmune disease diagnostics
Exhibit 61: APAC: Market overview of autoimmune disease diagnostics
Exhibit 62: Autoimmune disease diagnostics market in APAC 2016-2021 ($ millions)
Exhibit 63: Key initiatives of vendors fueling the launch of novel biomarkers
Exhibit 64: Key highlights of laboratory automation
Exhibit 65: Some of the consolidations witnessed during 2015-2016
Exhibit 66: Impact of drivers
Exhibit 67: Force field analysis of global autoimmune disease diagnostics market
Exhibit 68: Impact of drivers and challenges
Exhibit 69: Impact of trends on global autoimmune disease diagnostics market
Exhibit 70: Vendors' product development strategy for end-users
Exhibit 71: Competitive structure analysis of global autoimmune diagnostics market 2017-2021
Exhibit 72: Strategic success factors for companies in global autoimmune disease diagnostics market
Exhibit 73: Market penetration analysis of key vendors in autoimmune disease diagnostics 2015
Exhibit 74: Vendors' market share breakdown 2015
Exhibit 75: Abbott Laboratories: Profile
Exhibit 76: Abbott Laboratories: Strength assessment
Exhibit 77: Abbott Laboratories: Strategy assessment
Exhibit 78: Abbott Laboratories: Opportunity assessment
Exhibit 79: Beckman Coulter: Key highlights
Exhibit 80: Beckman Coulter: Strength assessment
Exhibit 81: Beckman Coulter: Strategy assessment
Exhibit 82: Beckman Coulter: Opportunity assessment
Exhibit 83: Bio-Rad Laboratories: Key highlights
Exhibit 84: Bio-Rad Laboratories: Strength assessment
Exhibit 85: Bio-Rad Laboratories: Strategy assessment
Exhibit 86: Bio-Rad Laboratories: Opportunity assessment
Exhibit 87: EUROIMMUN: Profile
Exhibit 88: EUROIMMUN: Strength assessment
Exhibit 89: EUROIMMUN: Strategy assessment
Exhibit 90: EUROIMMUN: Opportunity assessment
Exhibit 91: Inova Diagnostics: Key highlights
Exhibit 92: Inova Diagnostics: Strength assessment
Exhibit 93: Inova Diagnostics: Strategy assessment
Exhibit 94: Inova Diagnostics: Opportunity assessment
Exhibit 95: Roche Diagnostics: Key highlights
Exhibit 96: Roche Diagnostics: Strength assessment
Exhibit 97: Roche Diagnostics: Strategy assessment
Exhibit 98: Roche Diagnostics: Opportunity assessment
Exhibit 99: Siemens Healthcare: Key highlights
Exhibit 100: Siemens Healthcare: Strength assessment
Exhibit 101: Siemens Healthcare: Strategy assessment
Exhibit 102: Siemens Healthcare: Opportunity assessment

  • Global In-Vitro Diagnostics (IVD) Market Size, Status and Forecast 2022
    Published: 17-Nov-2017        Price: US 3300 Onwards        Pages: 100
    This report studies the global In-Vitro Diagnostics (IVD) market, analyzes and researches the In-Vitro Diagnostics (IVD) development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like - Roche - Siemens - Danaher - Abbott - BD - Alere - SYSMEX - BioMerieux - J&J - BIO-RAD - Hologic - KHB Market segment by Re......
  • Therapeutic Drug Monitoring (TDM) Market 2021: US, Europe, Japan--Supplier Shares, Competitive Strategies, Segment Forecasts, Innovative Technologies, Instrumentation Review
    Published: 15-Nov-2017        Price: US 8500 Onwards        Pages: 0
    Complete report $8,500. DataPack (test volumes, sales forecasts, supplier shares) $5,500.This new 313-page report from VPGMarketResearch.com contains 83 tables and provides analysis of the global therapeutic drug monitoring testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profiles of leading suppliers.The report provides test volume and sales forecasts by country and m......
  • France Therapeutic Drug Monitoring (TDM) Market 2021: Supplier Shares, Competitive Strategies, Sales Segment Forecasts, Innovative Technologies, Instrumentation Review
    Published: 15-Nov-2017        Price: US 2450 Onwards        Pages: 0
    This new 247-page report from VPGMarketResearch.com provides a comprehensive analysis of the French therapeutic drug monitoring market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers.The report provides test volume and sales forecasts by country and market segment for the following assays: Amikacin, Carbamazepine, Cyclosporin, Digoxin, Everolimus, Gentamicin, Levetiracetam, Lithium, Methotrexate, NAPA/Pr......
  • Germany Therapeutic Drug Monitoring (TDM) Market 2021: Supplier Shares, Competitive Strategies, Sales Segment Forecasts, Innovative Technologies, Instrumentation Review
    Published: 15-Nov-2017        Price: US 2450 Onwards        Pages: 0
    This new 249-page report from VPGMarketResearch.com provides a comprehensive analysis of the German therapeutic drug monitoring market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers.The report provides test volume and sales forecasts by country and market segment for the following assays: Amikacin, Carbamazepine, Cyclosporin, Digoxin, Everolimus, Gentamicin, Levetiracetam, Lithium, Methotrexate, NAPA/Pr......
  • Italy Therapeutic Drug Monitoring (TDM) Market 2021: Supplier Shares, Competitive Strategies, Sales Segment Forecasts, Innovative Technologies, Instrumentation Review
    Published: 15-Nov-2017        Price: US 2450 Onwards        Pages: 0
    This new 247-page report from VPGMarketResearch.com provides a comprehensive analysis of the Italian therapeutic drug monitoring market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers.The report provides test volume and sales forecasts by country and market segment for the following assays: Amikacin, Carbamazepine, Cyclosporin, Digoxin, Everolimus, Gentamicin, Levetiracetam, Lithium, Methotrexate, NAPA/P......
  • Japan Therapeutic Drug Monitoring (TDM) Market 2021: Supplier Shares, Competitive Strategies, Sales Segment Forecasts, Innovative Technologies, Instrumentation Review
    Published: 15-Nov-2017        Price: US 2750 Onwards        Pages: 0
    This new 247-page report from VPGMarketResearch.com provides a comprehensive analysis of the Japanese therapeutic drug monitoring market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers.The report provides test volume and sales forecasts by country and market segment for the following assays: Amikacin, Carbamazepine, Cyclosporin, Digoxin, Everolimus, Gentamicin, Levetiracetam, Lithium, Methotrexate, NAPA/......
  • Spain Therapeutic Drug Monitoring (TDM) Market 2021: Supplier Shares, Competitive Strategies, Sales Segment Forecasts, Innovative Technologies, Instrumentation ReviewReview
    Published: 15-Nov-2017        Price: US 2450 Onwards        Pages: 0
    This new 249-page report from VPGMarketResearch.com provides a comprehensive analysis of the Spanish therapeutic drug monitoring market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers.The report provides test volume and sales forecasts by country and market segment for the following assays: Amikacin, Carbamazepine, Cyclosporin, Digoxin, Everolimus, Gentamicin, Levetiracetam, Lithium, Methotrexate, NAPA/P......
  • UK Therapeutic Drug Monitoring (TDM) Market 2021: Supplier Shares, Competitive Strategies, Sales Segment Forecasts, Innovative Technologies, Instrumentation Review
    Published: 15-Nov-2017        Price: US 2450 Onwards        Pages: 0
    This new 247-page report from VPGMarketResearch.com provides a comprehensive analysis of the UK therapeutic drug monitoring market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers. The report provides test volume and sales forecasts by country and market segment for the following assays: Amikacin, Carbamazepine, Cyclosporin, Digoxin, Everolimus, Gentamicin, Levetiracetam, Lithium, Methotrexate, NAPA/Proca......
  • US Therapeutic Drug Monitoring (TDM) Market 2021: Supplier Shares, Competitive Strategies, Sales Segment Forecasts, Innovative Technologies, Instrumentation Review
    Published: 15-Nov-2017        Price: US 3500 Onwards        Pages: 0
    This new 249-page report from VPGMarketResearch.com provides a comprehensive analysis of the US therapeutic drug monitoring market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers.The report provides test volume and sales forecasts by country and market segment for the following assays: Amikacin, Carbamazepine, Cyclosporin, Digoxin, Everolimus, Gentamicin, Levetiracetam, Lithium, Methotrexate, NAPA/Procai......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs